The First Identification of the Unique Epitope induced by COVID 19 Vaccines
Medical and Clinical Case Reports · 2021
DOI: 10.33425/2768-6647.1003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical and Clinical Case Reports, 2021. Verfasst von George Pieczenik.
Abstract (Originalsprache)
Introduction The J&J vaccine was administered to over 2.3 million Americans. The J&J vaccine is a DNA adenovirus vector expressing the COVID-19 Spike protein. The Spike protein is 1.2 thousand amino acids long. The side effects of this vaccine are platelet suppression and blood clots. This was noted in 6 female patients. These 6 patients had antibodies which bound Platelet Factor Four protein (PL4). PL4 is 110 amino acids long. Given these numbers and assuming random nucleotide changes; then, one can calculate that a one nucletotide change (leading to a one amino acid change in the coding of the Spike protein's epitope) is responsible for the antibody binding to a PL4 epitope [1].
Zitieren
APA
Pieczenik, G. (2021). The First Identification of the Unique Epitope induced by COVID 19 Vaccines. Medical and Clinical Case Reports. https://doi.org/10.33425/2768-6647.1003
Vancouver
Pieczenik G. The First Identification of the Unique Epitope induced by COVID 19 Vaccines. Medical and Clinical Case Reports. 2021. doi:10.33425/2768-6647.1003
BibTeX
@article{Pieczenik2021,
author = {Pieczenik, George},
title = {The First Identification of the Unique Epitope induced by COVID 19 Vaccines},
journal = {Medical and Clinical Case Reports},
year = {2021},
doi = {10.33425/2768-6647.1003}
}
EUVIMED